825 INDUSTRIAL ROAD, SAN CARLOS, CA
Investor Presentation
News, Underwriting Agreement, Legal Opinion
Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Appoints Corleen Roche as Chief Financial Officer
Changes in Board, Management or Compensation
Shareholder votes
Q2
Q1
FY 2023
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence